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A key gene which regulates pigmentation in humans is the Melanocortin-1-Receptor 
(MC1R), that encodes a seven transmembrane G-protein coupled receptor which regulates 
cAMP levels in melanocytes. MC1R is activated by Melanocyte Stimulating Hormone 
(MSH) that is secreted by UV-irradiated keratinocytes in the “tanning” response [1]. MC1R 
loss-of-function is one means of generating light skin that likely facilitates vitamin D 
biosynthesis. This plausibly provided an evolutionary selective advantage in preventing 
lethal vitamin D deficiency at high latitude geographic locations. Negative selective pressure 
may have arisen at low latitude (higher UV intensity), due to photolysis of vital factors such 
as folate or potentially increased skin cancer risk in lightly pigmented individuals.
In Fitzpatrick skin type 1 individuals with light skin and red hair, >80 percent bear a 
dysfunctional variant in both MC1R alleles [2]. MC1R signaling upregulates tyrosinase, 
whose strong enzymatic activity results in synthesis of brown/black eumelanin. In contrast, 
loss-of-function MC1R variants produce lower cAMP and tyrosinase levels which induce 
formation of pheomelanin pigment. Pheomelanin not only lacks efficient ultraviolet (UV) 
shielding capacity, but it (or its biosynthetic intermediates) actively induce formation of 
reactive oxygen species (ROS) as well as DNA damage [3]. Of skin type 2 patients, ~60 
percent carry a single loss-of-function MC1R allele, whereas less than 20 percent of all 
individuals with skin type 3 or higher show one dysfunctional allele [2].
Melanoma incidence has risen over 30-fold in the last century [4]. Within the United States, 
melanoma incidence is about three fold higher in individuals of European descent than in 
Asians, and ~15 times higher than in individuals originating from South America and Africa 
[5]. As melanin levels largely influence melanoma risk, studies have examined the effect of 
yellow-red pheomelanin and brown-black eumelain on this melanoma risk [6].
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While UV is a key contributor to melanoma risk, with numerous UV signature mutations 
typically found throughout the melanoma genome, certain studies have suggested that 
additional mechanisms may contribute to melanoma risk. One of the suggested contributors 
is pheomelanin.
In a preclinical model, Mitra and colleagues studied mice carrying a conditional allele of 
BRAF V600E, that on a genetically black (Mc1r wildtype) background produces benign 
nevi. When crossed onto an Mc1r loss-of-function background, ~50% of the mice developed 
invasive melanomas. To ask whether the melanoma risk was related to the pheomelanin 
pigment in the Mc1r loss-of-function mice, (or a different biological consequence of having 
low cAMP signaling), a tyrosinase mutant allele (albinism) was crossed onto the red/Mc1r-
mutant BRAF(V600E) background, and was seen to ablate the melanoma risk. These studies 
suggested that pheomelanin or the pathway downstream of tyrosinase that is responsible for 
pheomelanin synthesis, contributes significantly to melanoma risk in this UV-independent 
genetically defined system [7]. In the absence of UV the skin of these redhaired mice also 
contained significantly increased lipid peroxidation and oxidative DNA damage as compared 
to skin from genetically matched albino-red animals. Recognition of pheomelanin and 
oxidative stress as UV-independent drivers of murine melanoma formation raised the 
question of how important this effect might be in humans. An intrinsic challenge to defining 
a UV-independent role of pheomelanin in human melanoma arises from difficulties in 
controlling for UV exposure among melanoma patients.
In this issue of JAMA Dermatology, Wendt et al. addressed this challenge by performing a 
case control study including 991 melanoma and 800 control patients, investigating the effect 
of MC1R variants on melanoma formation in UV-dependent and UV-independent contexts. 
Their study showed that individuals carrying two MC1R variants were at higher melanoma 
risk independent of UV-exposure symptoms, as compared to wild-type carriers.
Patients were stratified according to their MC1R mutation status, and five high-risk variants 
(“R”, complete loss of function, Ins86_87A, R142H, R151C, R160W, 146 D294H) and five 
low-risk variants (“r”, partial loss of function, V60L, D84E, V92M, I155T, R163Q) were 
genotyped. Adjustment for age and gender confirmed that more than 12 sunburns in life, 10 
or more sunburns below the age of 20, and severe signs of actinic skin damage were 
associated with significantly increased melanoma risk. Melanoma risk increased with the 
number of MC1R variants, suggesting that in this UV-dependent, but age and gender 
independent context, carriers of two or more variants were exposed to an over 2-fold higher 
risk (OR 2.13, 95% CI, 1.66–2.75; p<0.001) and single variant carriers to a 1.35 (95% CI, 
1.05–1.73; p=0.02) to 1.94-fold (95% CI, 1.45–2.60; p<0.001) increased risk.
To investigate UV-independent effects, the analysis was adjusted not only for age and 
gender, but also for variables related to sun exposure, such as a history of sunburns in 
childhood and adolescence, as well as clinically visible signs of actinic sun damage. Most 
interestingly, this adjustment revealed a significant correlation between melanoma risk and 
MC1R variant status, resulting in a 1.5 (95% CI, 1.01–2.21; p=0.04) to 2.63-fold (95% CI, 
1.82–3.81; p<0001) risk increase. Overall, this carefully performed study indicates that 
individuals carrying MC1R variants display a UV-independent significant intrinsic risk, 
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highlighting a need to better understand how MC1R variants, pheomelanin and ROS impact 
melanoma development and how to protect these individuals at elevated risk.
Morgan and colleagues proposed, a concept in which pheomelanin might either reduce or 
consume major antioxidants, or increase ROS generation directly [8]. Panzella and 
colleagues studied how pheomelanin, originating from human red hair, impacts the cellular 
redox system and autoxidation of reduced glutathione (GSH). GSH, a major cellular 
antioxidant, and reduced nicotinamide adenine dinucleotide (NADH), were both 
significantly diminished by pheomelanin [9]. The question of whether MC1R may also 
control various redox genes, like 8-oxoguanine DNA glycosylase and the apurinic 
apyrimidinic endonuclease 1 [10], or might influence lipid peroxidation via pheomelanin-
metal complexes [11] has not yet been fully clarified.
Understanding the danger originating from excessive cutaneous ROS, the question of how to 
protect individuals from an elevated intrinsic melanoma risk arises. Clearly, the correct and 
continuous application of UV-filter sunscreen reduces melanoma formation, and limits 
additional UV-induced ROS exposure as well as other UV-mediated carcinogenic events. As 
demonstrated in a large-scale carefully conducted randomized controlled trial in Australia, 
sunscreen application significantly reduced melanoma formation, by about 50% [12]. In 
BRAF(V600E) mice, a broad-spectrum sunfilter delayed the onset of UV induced 
melanomas, offering partial protection [13]. Although these studies strongly support efforts 
made in public health promotions encouraging usage of sunscreens, currently available 
sunfilters and prevention recommendations might not fully cover additional “intrinsic” risk 
factors, such as those associated with UV-independent pheomelanin related chemistry.
As UVA, a major ROS inducer, likely plays a significant role in melanoma formation, 
sunscreen manufacturers are seeking to incorporate ingredients that broadly filter both UVA 
and UVB. However, about half of all sunfilters promoted as "broad spectrum" protection 
exhibited only “low” or “medium” protection from UVA [14]. Therefore implementation of 
stricter guidelines, and implementation of extra sun care actions, such as physical sun 
protection and sun avoidance, must still be emphasized.
Carrying the findings of Wendt et al further, it may be valuable to consider whether UV-
independent (pheomelanin-related) carcinogenic risk might occur in lightskinned non-
redhaired individuals. While redhaired individuals usually contain MC1R redhair variant 
alleles, it is possible that other individuals with light skin (eg Fitzpatrick phototype II) may 
harbor related chemical events within their skin, perhaps to a lesser degree. The finding by 
Wendt et al is also consistent with the observation that melanoma is more likely to occur on 
non-sun-exposed anatomic locations of lightly pigmented individuals, as compared to non-
melanoma skin cancers (which are more tightly linked to UV).
One controversial preventative strategy might be to utilize anti-oxidants within sunfilters. 
While anti-oxidants might produce direct antagonistic chemical activities against 
pheomelanin associated reactive oxygen generation, several studies have demonstrated 
worsening behavior of various cancers, including melanoma [15] following use of the thiol 
antioxidant N-acetyl cysteine. It is possible that such anti-oxidants are inadvertently 
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protecting existing malignant (or premalignant) cell clones, from oxidative stress intrinsic to 
malignant transformation. If so, then it may be difficult—and hazardous—to utilize 
antioxidants as a preventative strategy. Such “shotgun” approaches seem ill-advised given 
our current understanding of the underlying chemistry. However it may be valuable to better 
understand which precise pro- and anti-oxidant species are involved, how the skin’s intrinsic 
antioxidant defenses work, and consider the role(s) of cutaneous pigments (especially dark 
brown/black eumelanin).
There are likely to be valuable lessons available to learn from nature, since humans with 
dark skin pigmentation or easy tanning capacity, exhibit profoundly lower risk of both 
melanoma and non-melanoma skin cancers. This lower risk occurs despite the relatively 
weak SPF value of eumelanin. Perhaps dark pigment is a more optimal anti-oxidant species 
which does not exert a survival benefit to pre-malignant cells. However the use of UV to 
produce dark pigmentation would clearly be a suboptimal and hazardous strategy.
The study by Wendt and colleagues provides valuable insight into a silent UV-independent 
melanoma risk that has no clear current preventative strategy. For now, lightly pigmented 
individuals need to understand the risks associated with sun exposure, and should utilize 
physical sun protection whenever possible. Regular skin examination and thorough self-
examination remain valuable steps towards halting melanoma mortality.
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